MedPath

The Stockholm Sleepy Brain Study: Effects of Sleep Deprivation on Cognitive and Emotional Processing in Young and Old

Not Applicable
Completed
Conditions
Sleep Deprivation
Registration Number
NCT02000076
Lead Sponsor
Mats Lekander
Brief Summary

The main purpose of this study is to investigate the effects of partial sleep deprivation (PSD) on resting state brain connectivity, emotional contagion, empathy, and emotional regulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
98
Inclusion Criteria
  • 20-30 years of age, inclusive OR 65-75 years of age, inclusive

  • Able to understand spoken and written Swedish (in order to understand instructions)

  • Normal or corrected-to-normal vision not using glasses

  • Not colour blind

  • Right-handed

  • Free from ferromagnetic objects in body

  • No history of any neurologic or psychiatric illness including drug abuse

  • No history of diabetes nor hypertension

    • No depression according to ratings using the Hospital Anxiety and Depression scale (HAD)
    • No insomnia according to ratings using the Insomnia Severity Index (ISI) and Karolinska Sleep Questionnaire (KSQ)
  • No use of psychotropic drugs

  • Not studying or working in medicine, psychology, nor behavioural science

  • Not suffering from severe seasonal allergy

  • No use of cortisone, anti-histamines, nor any other immune-modulating drugs

  • Habitual intake of no more than 4 cups of coffee per day or the equivalent in terms of caffeine

  • No daily use of nicotine

Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Blood oxygen level-dependent response in amygdala to angry faces (t/z-score from statistical parametric mapping)Change between 1st and 2nd MRI scanning session (approx. 1 month later)

This registration is made in order to pre-specify hypotheses in a basic science project. For a full list of outcomes and hypotheses, see study description (above).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Karolinska Institutet, Karolinska Universitetssjukhuset i Solna

🇸🇪

Stockholm, None/Not Applicable, Sweden

Karolinska Institutet, Karolinska Universitetssjukhuset i Solna
🇸🇪Stockholm, None/Not Applicable, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.